Workflow
Jiuyuan Gene Engineering(02566)
icon
Search documents
九源基因(02566)1月19日斥资25.26万港元回购2.84万股
智通财经网· 2026-01-19 11:29
Group 1 - The company Jiuyuan Gene (02566) announced a share buyback plan [1] - The company will spend HKD 252,600 to repurchase 28,400 shares [1]
九源基因1月19日斥资25.26万港元回购2.84万股
Zhi Tong Cai Jing· 2026-01-19 11:29
Group 1 - The company Jiuyuan Gene (02566) announced a share buyback on January 19, 2026, spending HKD 252,600 to repurchase 28,400 shares [1]
九源基因(02566.HK)1月19日耗资25.3万港元回购2.8万股
Ge Long Hui· 2026-01-19 11:24
Group 1 - The company, Jiuyuan Gene (02566.HK), announced a share buyback on January 19, spending HKD 253,000 to repurchase 28,000 shares [1]
九源基因(02566) - 翌日披露报表
2026-01-19 11:21
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: 杭州九源基因生物醫藥股份有限公司 呈交日期: 2026年1月19日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02566 | H股 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份(不包括庫存股份)數 目 | 佔有關事件前的現有已發 行股 ...
九源基因(02566.HK)1月14日耗资2.5万港元回购3000股
Ge Long Hui· 2026-01-14 12:16
Group 1 - The company, Jiuyuan Gene (02566.HK), announced a share buyback on January 14, spending HKD 25,000 to repurchase 3,000 shares [1]
九源基因1月14日斥资2.47万港元回购3000股
Zhi Tong Cai Jing· 2026-01-14 12:16
Group 1 - The company Jiuyuan Gene (02566) announced a share buyback plan [1] - The company will repurchase 3,000 shares at a cost of HKD 24.7 million [1] - The buyback is scheduled for January 14, 2026 [1]
九源基因(02566)1月14日斥资2.47万港元回购3000股
智通财经网· 2026-01-14 12:10
Group 1 - The company, Jiuyuan Gene (02566), announced a share buyback plan, committing to repurchase 3,000 shares at a cost of HKD 24.7 million [1]
九源基因(02566) - 翌日披露报表
2026-01-14 12:08
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: 杭州九源基因生物醫藥股份有限公司 呈交日期: 2026年1月14日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02566 | 說明 | H股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | 庫存股份變動 | | | | 事件 | | 已發行股份(不包括庫存股份)數 目 ...
智通港股回购统计|1月14日
智通财经网· 2026-01-14 01:41
Group 1 - The article discusses the share buybacks conducted by various companies on January 13, 2026, with Tencent Holdings (00700) having the largest buyback amount of 636 million yuan for 1.012 million shares [1][2] - Other notable companies involved in the buyback include Xiaomi Group (01810) with 4 million shares repurchased for 152 million yuan, and Sunny Optical Technology (02382) with 640,000 shares for approximately 41.79 million yuan [1][2] - The total number of shares repurchased by Tencent Holdings in the year reached 11 million, representing 1.199% of its total share capital [2] Group 2 - The buyback activities reflect a strategic move by companies to enhance shareholder value and signal confidence in their financial health [1][2] - Companies like Weigao Group (01066) and Xinli International (00732) also showed significant buyback activity, with Weigao repurchasing 27,440 shares for 1.4962 million yuan, representing 6.519% of its total share capital [2] - The data indicates a trend among companies to engage in share buybacks as a method to return capital to shareholders and potentially boost stock prices [1][2][3]
九源基因(02566.HK)1月13日耗资23.9万港元回购3万股
Ge Long Hui· 2026-01-13 12:09
格隆汇1月13日丨九源基因(02566.HK)公告,1月13日耗资23.9万港元回购3万股。 ...